| ebi-pharm ag - Wobenzym, magensaftresistente Filmtabletten | | 67943 | | 01 | | Wobenzym | | magensaftresistente Filmtabletten | | M09AB52 | | Trypsin, Kombinationen | | 19.07.2022 | | |
| | Composition | | rutosidum trihydricum 50.00 mg, papainum 32.80 mg corresp. papainum 164 U., bromelainum ex truncus 45.00 mg corresp. bromelainum ex truncus 225 U., trypsinum 24.00 mg corresp. trypsinum 720 U., chymotrypsinum 0.75 mg corresp. chymotrypsinum 300 U., pancreatis pulvis 100.00 mg corresp. pancreatis pulvis 300 U., E 223 in Spuren, maltodextrinum, saccharum max. 33.39 mg, maydis amylum, cellulosum microcristallinum, lactosum monohydricum 126.50 mg, magnesii stearas, amylum pregelificatum, silica colloidalis anhydrica, macrogolum 6000, talcum, Überzug: acidi methacrylici et methylis methacrylatis polymerisatum 1:1, natrii laurilsulfas, macrogolum 6000, talcum, triethylis citras, pro compresso obducto corresp., natrium 0.0032 mg. | | Packungsbestandteile | | magensaftresistente Filmtabletten | | | | Principe actif | Concentr. |
|---|
| Bromelainum ex Truncus | 45 mg correspond Bromelainum ex Truncus 225 U | | Chymotrypsinum | 0.75 mg correspond Chymotrypsinum 300 U | | Pancreatis Pulvis | 100 mg correspond Pancreatis Pulvis 300 U | | Papaine | 32.8 mg correspond Papaine 164 U | | Rutosidum Trihydricum | 50 mg | | Trypsinum | 24 mg correspond Trypsinum 720 U |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Acidi Methacrylici | | Überzug | | Amylum Pregelificatum | | | | Cellulosum Microcristallinum | | | | E 223 | | conserv. | | In Spuren | | | | Lactose Monohydrate | 126.5 mg | | | Macrogol | 6000 | | | Magnesii Stearas | | | | Maltodextrine | | | | Maydis Amylum | | | | Methylis Methacrylatis Polymerisatum | | | | Natrii Laurilsulfas | | | | Pro Compresso Obducto | | | | Saccharum | 33.39 mg | | | Silica Colloidalis Anhydrica | | | | Talcum | | | | Triethylis Citras | | |
|
| |
|
